## Author Contributions {.page_break_before}

SL conceptualised and developed the platform and wrote the manuscript.
AM implemented the local deployment functionality.
NK implemented benchmarking procedures.
CW architected the BioChatter Next server infrastructure.
QM oversaw the development and deployment of the BioChatter Next server environment.
SF integrated BioChatter continuous integration pipelines and developed both front-end and back-end components for the BioChatter Next server.
JSR supervised the project, revised the manuscript, and acquired funding.
All authors read and approved the final manuscript.

## Acknowledgements

We thank Hanna Schumacher, Daniel Dimitrov, Pau Badia i Mompel, and Aurelien Dugourd for feedback on the original draft of the manuscript and the software.

SL has received funding from the European Unionâ€™s Horizon 2020 research and innovation programme under grant agreement No 965193 (DECIDER).

## Conflict of Interest

JSR reports funding from GSK, Pfizer and Sanofi and fees/honoraria from Travere Therapeutics, Stadapharm, Pfizer, Grunenthal, and Astex Pharmaceuticals.

## References {.page_break_before}

<!-- Explicitly insert bibliography here -->
<div id="refs"></div>
